Clinical Trial Update: A Double-Blind Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity Disorder [Phase 4]

View source ↗

Summary

A Phase 4 double-blind study comparing naltrexone to placebo in adults with attention deficit hyperactivity disorder was terminated, with results posted in 2016…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Naltrexone (Naltrexone)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: ADHD, Attention Deficit Hyperactivity Disorder | Phase 4 | Status: TERMINATED | Results posted: 2016-04-12